Antibiotic susceptibility of common pediatric uropathogens in the United States

Clinical Infectious Diseases

Volumn 59, Issue 5, 2014, Pages 750-752

  Tamma, Pranita D ^a   Sklansky, Daniel J ^b   Palazzi, Debra L ^c   Swami, Sanjeev K ^d   Milstone, Aaron M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Wisconsin Health   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFAZOLIN; CEFTRIAXONE; COTRIMOXAZOLE; NITROFURANTOIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CHILD CARE; ESCHERICHIA COLI; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; URINARY TRACT INFECTION; CHILD; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 84907389111     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu360     Document Type: Letter

References (5)

1. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595-610.
2. Tamma PD, Robinson GL, Gerber JS, et al. Pediatric antimicrobial susceptibility trends across the United States. Infect Cont Hosp Epidemiol 2013; 34:1244-51.
3. Turnidge JD; Subcommittee on Antimicrobial Susceptibility Testing of the Clinical and Laboratory Standards Institute. Cefazolin and Enterobacteriaceae: rationale for revised susceptibility testing breakpoints. Clin Infect Dis 2011; 52:917-24.
4. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-86.
5. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; approved standard. 24th informational supplement. In: CLSI Document M100-S24. Wayne, PA: CLSI, 2014.